Geneos Wealth Management Inc. Charles River Laboratories International, Inc. Transaction History
Geneos Wealth Management Inc.
- $2.77 Billion
- Q4 2024
A detailed history of Geneos Wealth Management Inc. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Geneos Wealth Management Inc. holds 108 shares of CRL stock, worth $12,810. This represents 0.0% of its overall portfolio holdings.
Number of Shares
108
Previous 9,885
98.91%
Holding current value
$12,810
Previous $1.95 Million
99.02%
% of portfolio
0.0%
Previous 0.07%
Shares
17 transactions
Others Institutions Holding CRL
# of Institutions
697Shares Held
50.4MCall Options Held
122KPut Options Held
239K-
Vanguard Group Inc Valley Forge, PA6.16MShares$731 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$604 Million0.02% of portfolio
-
State Street Corp Boston, MA2.18MShares$259 Million0.02% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.81MShares$214 Million0.79% of portfolio
-
Allspring Global Investments Holdings, LLC1.77MShares$211 Million0.5% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $6.03B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...